Neutropenia during treatment of rheumatoid arthritis with levamisole.

AUTOR(ES)

Williams, G T

RESUMO

Of 60 patients with rheumatoid arthritis treated with levamisole 35% showed a persistent decrease in neutrophil counts from pre-treatment levels and 6 (10%) develped severe neutropenia of less than 1.0 X 10(9)/1. One of these neutropenic patients recoverd without stopping therapy and the other 5 patients recovered rapidly when the drug was withdrawn. In some patients neutropenia recurred on reinstitution of levamisole.

Documentos Relacionados

• Cellular phagocytic studies in rheumatoid arthritis patients treated with levamisole.
• Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.
• Rectal ulcer associated with levamisole.
• Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes.
• Continuous and intermittent levamisole. A controlled trial.